Sign in

You're signed outSign in or to get full access.

Kevin J. Detz

Executive Vice President and Chief Financial Officer at SONIDA SENIOR LIVING
Executive

About Kevin J. Detz

Kevin J. Detz, age 45, is Executive Vice President and Chief Financial Officer of Sonida Senior Living (SNDA) and joined in May 2022 after senior finance roles at Aimbridge Hospitality, Goldman Sachs’ Real Estate Management Division, and Ernst & Young; he earned a magna cum laude business administration degree from Duquesne University, is a Certified Public Accountant, and an AICPA member . Company performance during his tenure shows strong shareholder value creation in 2024 with the “value of a $100 investment” at $259.33 versus $78.28 in 2023, alongside a narrowing net loss to $(3,280)k in 2024 from $(21,107)k in 2023 and $(54,401)k in 2022; 2024 revenue used for the short‑term incentive was $252,866,232 . His compensation is structured with a base salary and at‑risk pay driven by revenue, operating margin, Adjusted AFFO, and retention goals in the STI, and multi‑year PSAs tied to an Adjusted Equity Yield metric through year‑end 2026 .

Past Roles

OrganizationRoleYearsStrategic Impact
Aimbridge HospitalityEVP & Operational CFOJan 2020–Apr 2022Led finance operations for global third‑party hotel manager
Aimbridge HospitalitySVP & Chief Accounting OfficerOct 2016–Dec 2019Oversaw accounting and reporting functions
Aimbridge HospitalitySVP & ControllerMar 2014–Sep 2016Built controllership and internal controls
Goldman Sachs – Real Estate Management Div.Vice President & ControllerDec 2007–Mar 2014Finance leadership in real estate asset operations
Ernst & Young LLPAudit practice2002–2007Public accounting foundation

External Roles

OrganizationRoleYearsStrategic Impact
American Institute of Certified Public Accountants (AICPA)MemberN/AProfessional standards and network
Duquesne UniversityB.S. Business Administration, magna cum laudeN/AFoundational education
Certified Public AccountantCPA credentialN/ATechnical finance/accounting expertise

Fixed Compensation

Metric20232024
Salary ($)$405,233 $417,368
Bonus ($)$75,000 (sign‑on paid Mar 2023)
Non‑Equity Incentive Plan Compensation ($)$275,918 $292,740
Stock Awards ($ grant‑date fair value, ASC 718)$713,608 $1,502,611
Total Compensation ($)$1,469,759 $2,212,719
Employment Agreement TermsValue
Base salary (minimum)$400,000
Target annual bonus (% of base)70%
Sign‑on$75,000 (paid Mar 2023)
Initial equity on hire30,000 performance‑based restricted shares
Severance frameworkBenefits if terminated without “Cause” or for “Good Reason,” including in a “Change in Control” (specific multiples not disclosed)

Performance Compensation

2024 Short‑Term Incentive (STI) Plan – Design, Targets, Results, and Payout

MetricWeightingThresholdTargetMaxActual ResultPayout Factor
Revenue30% $243,125,900 $255,922,000 $268,718,100 $252,866,232 26.4%
Operating Margin35% 26.50% 27.54% 28.75% 27.23% 29.8%
Adjusted AFFO (as adjusted)30% $(4,563,596) $(2,399,192) $1,929,616 $(2,018,613) 32.6%
Employee Retention Index5% 104.3 107.3 110.3 109 7.8%
Total100%96.6%
  • Compensation Committee discretion: Given the significant positive impact of the 2024 acquisition program, the Committee adjusted payout percentages so each NEO received 100% of target, resulting in Detz’s STI payout of $292,740 .

Long‑Term Equity Incentive Awards (LTI) – 2024 Grants and PSA Framework

NEORSAs Granted (shares)PSAs Granted (shares)PSA MetricPerformance PeriodRSA Vesting
Kevin J. Detz25,863 25,862 Adjusted Equity Yield 3‑year ending Dec 31, 2026 33%, 33%, 34% on Apr 5, 2025/2026/2027
  • Award agreements: Time‑based restricted stock does not automatically vest on change‑in‑control unless assumed and subsequently terminated without cause or for good reason within one year; PSAs can vest (full or partial) at transaction close depending on shareholder consideration; death/disability provisions apply as described in award agreements .
  • Change‑in‑control plan treatment: The 2019 Plan provides acceleration and target/actual performance vesting rules; if not assumed, awards become fully exercisable and restrictions lapse, then terminate post‑closing; if assumed, involuntary terminations within up to 24 months can trigger accelerated vesting .

Equity Ownership & Alignment

Beneficial Ownership

HolderShares Beneficially Owned% of Class
Kevin J. Detz177,938 <1% (*)
  • Composition note: Includes direct and indirect ownership (children) and unvested restricted stock, per Form 4 references .
  • Anti‑hedging/pledging: Hedging is prohibited; pledging is prohibited for directors and officers (general policy notes pre‑approval for employees, but compensation practices explicitly prohibit pledging by directors/officers) .
  • Stock ownership guidelines: Company maintains executive and director guidelines; specific multiples not disclosed in the proxy .

Outstanding Awards (FY‑End 2024)

TypeGrant IdentifierShares Unvested/UnearnedMarket Value at 12/31/2024
RSA (time‑based)(i) May 12, 20222,867 $66,170
RSA (time‑based)(c) Apr 4, 20235,600 $129,248
RSA (time‑based)(l) Apr 5, 202425,863 $596,918
PSA (performance)(j) May 12, 202212,092 (forfeited after 12/31/2024) $279,083
PSA (performance)(k) May 12, 202230,000 $692,400
PSA (performance)(g) Apr 4, 202319,600 $452,368
PSA (performance)(h) Jan 26, 202360,000 $1,384,800
PSA (performance)(m) Apr 5, 202425,862 $596,895
  • Market value calculated using $23.08 closing price on Dec 31, 2024 .
  • Vesting schedules: RSAs typically vest 33/33/34 across three anniversaries; PSAs subject to specified performance conditions; several 2022 PSA tranches were forfeited after year‑end 2024, indicating challenging hurdle attainment .

Employment Terms

TermDetail
Role & start dateEVP & CFO; joined May 2022
Employment agreementEntered April 2022 (Exhibit 10.1 referenced)
Cash compBase salary not less than $400,000; target bonus 70% of base
Sign‑on$75,000 paid March 2023; 30,000 performance‑based restricted shares
SeveranceEntitled to certain payments/benefits if terminated without “Cause” or for “Good Reason,” including in a “Change in Control” (specific multiples not disclosed)
Equity CIC treatment2019 Plan provides acceleration/vesting rules; assumed awards may accelerate upon involuntary termination within up to 24 months; if not assumed, awards vest fully then terminate post‑closing
Award agreementsTime‑based RSAs do not auto‑vest on CIC unless assumed and later terminated; PSAs may vest at closing depending on consideration value; pro‑rata vesting on death/disability subject to targets
ClawbacksRobust recoupment policy for cash and equity incentives on restatement; supplemental policy for misconduct enabling repayment/forfeiture
Hedging/PledgingHedging prohibited; pledging prohibited for directors/officers
Say‑on‑pay outcome (2025)Advisory approval: For 17,046,441; Against 33,976; Abstain 20,785; 847,724 broker non‑votes

Performance Compensation

ComponentMetricWeightingTargetActualPayoutVesting
STI (Cash)Revenue30% $255,922,000 $252,866,232 26.4%; adjusted to 100% overall N/A
STI (Cash)Operating Margin35% 27.54% 27.23% 29.8%; adjusted to 100% overall N/A
STI (Cash)Adjusted AFFO30% $(2,399,192) $(2,018,613) 32.6%; adjusted to 100% overall N/A
STI (Cash)Employee Retention Index5% 107.3 109 7.8%; adjusted to 100% overall N/A
LTI (Equity)Adjusted Equity Yield (PSAs)50% of LTI mix 3‑year cumulative target In‑progressVests at end of performance period Performance‑based; 3‑year ending 12/31/2026
LTI (Equity)RSAs (time‑based)50% of LTI mix N/AN/AN/A33/33/34 over 3 anniversaries

Investment Implications

  • Pay-for-performance calibration: Detz’s at‑risk mix is high with STI tied to revenue, margin, and AFFO, and PSAs tied to multi‑year Adjusted Equity Yield; 2024 Committee discretion to pay 100% of STI despite a 96.6% formula outcome signals supportive, acquisition‑adjusted judgment that may soften pure formulaic rigor .
  • Vesting cadence and potential selling pressure: Meaningful RSA tranches vest in 2025–2027 (25,863 RSAs granted in 2024 plus earlier time‑based awards), creating periodic liquidity events that could translate to selling pressure depending on personal diversification needs and guideline compliance; PSAs remain contingent through 2026 with some 2022 tranches forfeited, indicating challenging hurdles .
  • Alignment and governance: Beneficial ownership is <1%, with strong anti‑hedging/anti‑pledging policies and robust clawbacks; double‑trigger vesting and plan CIC mechanics reduce windfall risk and enhance shareholder alignment .
  • Execution track record: Shareholder value improved materially in 2024 (TSR proxy measure at $259.33 per $100), and net losses narrowed significantly, with STI actuals demonstrating operational progress; continued PSA attainment will be a key watch‑item for medium‑term value creation .
  • Shareholder support: 2025 say‑on‑pay passed with substantial support, reducing near‑term governance overhang on compensation design .